J&J recalls 70,000 Invega syringes

* Recalls 70,000 Invega syringes due to cracks

* Issues resolved and production resumes

CHICAGO Feb 16 (Reuters) - Johnson & Johnson (JNJ.N) said it has recalled 70,000 syringes filled with the antipsychotic drug Invega because of cracks in the syringes.

A company spokesman said the issue, discovered during routine testing, has been resolved and production of the syringes has resumed at its Belgium manufacturing facility.

J&J has had to recall scores of products -- from over-the-counter drugs to contact lenses -- because of manufacturing problems. (Reporting by Debra Sherman, editing by Gerald E. McCormick)